Compare ICCC & TZOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICCC | TZOO |
|---|---|---|
| Founded | 1982 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.8M | 60.3M |
| IPO Year | 1995 | 2003 |
| Metric | ICCC | TZOO |
|---|---|---|
| Price | $10.02 | $10.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.50 |
| AVG Volume (30 Days) | 28.0K | ★ 365.6K |
| Earning Date | 05-15-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.85 | N/A |
| EPS | 0.21 | ★ 0.23 |
| Revenue | ★ $26,493,169.00 | N/A |
| Revenue This Year | N/A | $11.98 |
| Revenue Next Year | N/A | $9.52 |
| P/E Ratio | ★ N/A | $23.20 |
| Revenue Growth | ★ 51.64 | N/A |
| 52 Week Low | $4.52 | $4.72 |
| 52 Week High | $10.25 | $14.18 |
| Indicator | ICCC | TZOO |
|---|---|---|
| Relative Strength Index (RSI) | 73.69 | 69.16 |
| Support Level | $5.85 | $9.40 |
| Resistance Level | N/A | $10.15 |
| Average True Range (ATR) | 0.50 | 0.50 |
| MACD | 0.12 | -0.04 |
| Stochastic Oscillator | 97.37 | 93.82 |
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.